Literature DB >> 23799574

Thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell apoptosis in breast cancer cells.

H Kong1, L Tao, K Qi, Y Wang, Q Li, J Du, Z Huang.   

Abstract

The present study was conducted to explore the efficacy of suicide gene therapy with thymidine kinase (TK) in combination with cytosine deaminase (CD) for breast cancer. The expression of CD/TK was detected in the infected cells by RT-PCR. The killing effect on MCF-7 cells following treatment was analyzed by MTT assay. The morphological characteristics of the cells were observed by electron microscopy, and the distribution of the cell cycle was analyzed by flow cytometry. Caspase‑3 and -8 activities were detected by absorption spectrometry. Cytotoxic assays showed that cells transfected with CD/TK became more sensitive to the prodrugs. Morphological features characteristic of apoptosis were noted in the MCF‑7 cells via electron microscopy. The experimental data showed that the proportion of MCF-7 cells during the different phases of the cell cycle varied significantly following treatment with the prodrugs. The activity of caspase‑3 gradually increased following treatment with increasing concentrations of the prodrugs. We conclude that the TK/ganciclovir and CD/5-fluorocytosine suicide gene system used here induces apoptosis in breast cancer cells, and provides a promising treatment modality for breast cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23799574     DOI: 10.3892/or.2013.2562

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  A double suicide gene system driven by vascular endothelial growth factor promoter selectively kills human hepatocellular carcinoma cells.

Authors:  Kai Wu; Liucheng Yang; Zonghai Huang; Haijun Zhao; Jianjun Wang; Shuai Xu
Journal:  Oncol Lett       Date:  2016-03-22       Impact factor: 2.967

2.  Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics.

Authors:  Rakesh K Tekade; Muktika Tekade; Manoj Kumar; Abhay S Chauhan
Journal:  Pharm Res       Date:  2014-09-10       Impact factor: 4.200

3.  Suicide gene therapy-mediated purine nucleoside phosphorylase/fludarabine system for in vitro breast cancer model with emphasis on evaluation of vascular endothelial growth factor promoter efficacy.

Authors:  Akbar Abbaspour; Abdolreza Esmaeilzadeh; Ali Sharafi
Journal:  3 Biotech       Date:  2021-02-24       Impact factor: 2.406

4.  Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein.

Authors:  K A Lears; J J Parry; R Andrews; K Nguyen; T J Wadas; B E Rogers
Journal:  Cancer Gene Ther       Date:  2015-04-03       Impact factor: 5.987

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.